Effects of yam and diosgenin on calpain systems in skeletal muscle of ovariectomized rats

Taiwanese Journal of Obstetrics and Gynecology

Volumn 47, Issue 2, 2008, Pages 180-186

  Hsu, Kung Hao ^a   Chang, Chi Chen ^b   Tsai, Horng Der ^c   Tsai, Fuu Jen ^b   Hsieh, Yao Yuan ^b  

^a TUNGHAI UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Calpain; Diosgenin; Menopause; Ovariectomy; Yam

Indexed keywords

BETA ACTIN; CALPAIN 1; CALPAIN 2; DIOSGENIN; HERBACEOUS AGENT; ISOENZYME; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; FEMALE; HORMONE SUBSTITUTION; MENOPAUSE; NONHUMAN; OVARIECTOMY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; YAM;

EID: 47349108514     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(08)60077-7     Document Type: Article

References (37)

1. Benghuzzi H, Tucci M, Eckie R, Hughes J. The effects of sustained delivery of diosgenin on the adrenal gland of female rats. Biomed Sci Instrum 2003;39:335-40.
2. Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001; 4:144-50.
3. Tucci M, Benghuzzi H. Structural changes in the kidney associated with ovariectomy and diosgenin replacement therapy in adult female rats. Biomed Sci Instrum 2003;39: 341-6.
4. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-75.
5. Rasmussen SK, Urhammer SA, Berglund L, et al. Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 2002;51:3561-7.
6. 2+-activated protease possibly involved in myofibrillar protein turnover. Partial characterization of the purified enzyme. Biochemistry 1976;15:2159-67.
7. Suzuki K, Imajoh S, Emori Y, Kawasaki H, Minami Y, Ohno S. Regulation of activity of calcium activated neutral protease. Adv Enzyme Regul 1988;27:153-69.
8. Sugita H, Ishiura S, Suzuki K, Imahori K. Ca-activated neutral protease and its inhibitors: in vitro effect on intact myofibrils. Muscle Nerve 1980;3:335-9.
9. Goll DE, Thompson VF, Taylor RG, Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays 1992;14:549-56.
10. Yoshimura N, Murachi T, Heath R, Kay J, Jasani B, Newman GR. Immunogold electron-microscopic localisation of calpain I in skeletal muscle of rats. Cell Tissue Res 1986;244:265-70.
11. Hong DH, Huan J, Ou BR, Yeh JY, Saido TC, Cheeke PR, Forsberg NE. Protein kinase C isoforms in muscle cells and their regulation by phorbol ester and calpain. Biochim Biophys Acta 1995;1267:45-54.
12. Ilian MA, Forsberg NE. Gene expression of calpains and their specific endogenous inhibitor, calpastatin, in skeletal muscle of fed and fasted rabbits. Biochem J 1992;287: 163-71.
13. Gamerdinger M, Manthey D, Behl C. Oestrogen receptor subtype-specific repression of calpain expression and calpain enzymatic activity in neuronal cells - implications for neuroprotection against Ca-mediated excitotoxicity. J Neurochem 2006;97:57-68.
14. Wong JK, Le HH, Zsarnovszky A, Belcher SM. Estrogens and IC1182,780 (Faslodex) modulate mitosis and cell death in immature cerebellar neurons via rapid activation of p44/p42 mitogen-activated protein kinase. J Neurosci 2003;23:4984-95.
15. Duan WR, Ito M, Lee EJ, Chien PY, Jameson JL. Estrogen regulates a tissue-specific calpain in the anterior pituitary. Biochem Biophys Res Commun 2002;295:261-6.
16. Tiidus PM, Zajchowski S, Enns D, Holden D, Bombardier E, Belcastro AN. Differential effect of oestrogen on post-exercise cardiac muscle myeloperoxidase and calpain activities in female rats. Acta Physiol Scand 2002;174:131-6.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
19. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2000; 288:321-33.
20. Rosser A. The day of the yam. Nurs Times 1985;81:47.
21. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805-13.
22. Wu WH, Liu LY, Chung CJ, Jou HJ, Wang TA. Estrogenic effect of yam ingestion in healthy postmenopausal women. J Am Coll Nutr 2005;24:235-43.
23. Guroff G. A neutral, calcium-activated proteinase from the soluble fraction of rat brain. J Biol Chem 1964;239:149-55.
24. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J 1997;328:721-32.
25. Suzuki K, Sorimachi H, Yoshizawa T, Kinbara K, Ishiura S. Calpain: novel family members, activation, and physiologic function. Biol Chem Hoppe Seyler 1995;376:523-9.
26. Huang Y, Wang KK. The calpain family and human disease. Trends Mol Med 2001 ;7:355-62.
27. Wang KK, Yuen PW. Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol Sci 1994;15:412-9.
28. Kent MP, Spencer MJ, Koohmaraie M. Postmortem proteolysis is reduced in transgenic mice overexpressing calpas-tatin. J Anim Sci 2004;82:794-801.
29. Suzuki K, Ohno S. Calcium activated neutral protease: structure-function relationship and functional implications. Cell Struct Funct 1990;15:1-6.
30. Takai Y, Yamamoto M, Inoue M, Kishimoto A, Nishizuka Y. A proenzyme of cyclic nucleotide-independent protein kinase and its activation by calcium-dependent neutral protease from rat liver. Biochem Biophys Res Commun 1977;77:542-50.
31. Stalker TJ, Gong Y, Scalia R. The calcium-dependent protease calpain causes endothelial dysfunction in type 2 diabetes. Diabetes 2005;54:1132-40.
32. Otani K, Han DH, Ford EL, et al. Calpain system regulates muscle mass and glucose transporter GLUT4 turnover. J Biol Chem 2004;279:20915-20.
33. Tiidus PM, Holden D, Bombardier E, Zajchowski S, Enns D, Belcastro A. Estrogen effect on post-exercise skeletal muscle neutrophil infiltration and calpain activity. Can J Physiol Pharmacol 2001 ;79:400-6.
34. Piccone CM, Brazeau GA, McCormick KM. Effect of oestrogen on myofibre size and myosin expression in growing rats. Exp Physiol 2005;90:87-93.
35. Shiba E, Kim S, Fujitani M, Kambayashi Jl, et al. Possible involvement of calpain in the growth of estrogen receptor positive breast cancer cells. Anticancer Res 1996;16:773-7.
36. 2+-dependent neutral protease (Calpain) activity in breast cancer tissue and estrogen receptor status. Breast Cancer 1996;3:13-7.
37. Murayama A, Fukai F, Murachi T. Action of calpain on the basic estrogen receptor molecule of porcine uterus. J Biochem 1984;95:1697-704.